Cancer Vaccine Institute News

Last week, KING 5 News featured ongoing research at the Cancer Vaccine Institute (CVI) to develop COLOVAC, a preventive vaccine designed to stop colon cancer before it starts. The segment included interviews with CVI Director Dr. Nora Disis and Becky Bruhn, a Seattle resident whose recent cancerous polyp illustrates the importance of early detection and need for new prevention tools. Colon cancer remains one of the leading causes of cancer death in the United States, and rate

Dr. Denise Cecil, CVI Principal Scientist. PC: AP Photos Colon cancer is the second leading cause of cancer death in the United States, with diagnoses rising among adults under 55. In response, the Cancer Vaccine Institute (CVI) at UW Medicine is developing COLOVAC, a first-in-class vaccine designed to intercept colon cancer at its earliest stages, offering hope to those at the highest risk. Rising Colon Cancer Risk Colon cancer remains one of the most consequential cancers o

Friday, June 15th-16th, 2023 In-person in Seattle, Washington & Virtually The CVI Circle - Empowering Patients, Advancing Science ("The CVI Circle") is an event organized by the Cancer Vaccine Institute at the University of Washington to bring together patients, clinicians, and researchers. We are proud to partner with our amazing Patient Advisory Council the planning of this event. Our goal is for everyone - patients, clinicians, & scientists - to have the opportunity to pa

American Cancer Society article publishes a piece featuring Dr. Disis on how colon cacer vaccines may aid prevention of the disease in the f